- 著者
- 
             
             Koichi Hashimoto
             
             Hajime Maeda
             
             Kyohei Miyazaki
             
             Masahiro Watanabe
             
             Sakurako Norito
             
             Ryo Maeda
             
             Yohei Kume
             
             Takashi Ono
             
             Mina Chishiki
             
             Kazuhide Suyama
             
             Masatoki Sato
             
             Mitsuaki Hosoya
             
          
- 出版者
- National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee
- 雑誌
- Japanese Journal of Infectious Diseases (ISSN:13446304)
- 巻号頁・発行日
- vol.74, no.2, pp.154-156, 2021-03-31 (Released:2021-03-24)
- 参考文献数
- 13
- 被引用文献数
- 
             
             1
             
             
             3
             
             
          
        
        Subacute sclerosing panencephalitis (SSPE) is a late-onset, intractable, and fatal viral disease caused by persistent infection of the central nervous system with a measles virus mutant (SSPE virus). In Japan, interferon-α and ribavirin are administered intracerebroventricularly to patients with SSPE. However, as the therapeutic effect is insufficient, more effective drugs are needed. Favipiravir, which is clinically used as an anti-influenza drug, demonstrates anti-viral effects against RNA viruses. In this study, the antiviral effect of favipiravir against measles virus (Edmonston strain) and SSPE virus (Yamagata-1 strain) was examined in vitro. The 50% effective concentration (EC50) of favipiravir (inhibiting viral plaque formation by 50%) against Edmonston and Yamagata-1 strains were 108.7 ± 2.0 μM (17.1 ± 0.3 μg/mL) and 38.6 ± 6.0 μM (6.1 ± 0.9 μg/mL), respectively, which were similar to those of ribavirin. The antiviral activity of favipiravir against the SSPE virus was demonstrated for the first time in this study.